Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Zintellect
- National University of Singapore
- Harvard University
- Indiana University
- University of London
- The University of Queensland
- University of Leeds
- Center for Biologics Evaluation and Research (CBER)
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Technical University of Munich
- University of Beira Interior
- University of British Columbia
- University of Maryland, Baltimore
- University of Otago
- BU Pulmonary
- Center for Drug Evaluation and Research (CDER)
- Central Michigan University
- Hong Kong Polytechnic University
- National Institute of Allergy and Infectious Diseases, NIH
- Queen Mary University of London
- UNIVERSITY OF MELBOURNE
- UiT The Arctic University of Norway
- Universidade do Minho
- University of Idaho
- University of Michigan
- University of Oxford
- University of Texas at Austin
- 17 more »
- « less
-
Field
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago
therapeutic applications. The specific focus will be immune responses to Cas proteins used in gene editing. Cas9 proteins derived from human pathogens are the most extensively studied CRISPR-Cas gene editors
-
-UV-C) disinfection technologies to prevent the introduction and spread of Highly Pathogenic Avian Influenza (HPAI) in commercial poultry operations. The project integrates environmental virology, UV
Searches related to pathogen
Enter an email to receive alerts for pathogen positions